{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:59:25Z","timestamp":1787954365370,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.amjmed.2016.09.015","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T01:04:44Z","timestamp":1476666284000},"page":"119-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored \u2026 Until Now"],"prefix":"10.1016","volume":"130","author":[{"given":"Barry J.","family":"Maron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Rowin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Braunwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2016.09.015_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"39","key":"10.1016\/j.amjmed.2016.09.015_bib2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2016.09.015_bib3","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.09.015_bib5","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.112.123174","article-title":"Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease","volume":"126","author":"Maron","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality shaped by 50 years of clinical research and practice","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjmed.2016.09.015_bib7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl 4","key":"10.1016\/j.amjmed.2016.09.015_bib8","first-page":"3","article-title":"Idiopathic hypertrophic subaortic stenosis. I. a description of the disease based upon a analysis of 64 patients","volume":"30","author":"Braunwald","year":"1964","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.CIR.26.2.161","article-title":"Hypertrophic subaortic stenosis \u2013 a broadened concept","volume":"26","author":"Braunwald","year":"1962","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib10","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.97.5.461","article-title":"Spontaneous variablity of left ventricular outfow tract gradient in hypertrophic obstructive cardiomyopathy","volume":"97","author":"Kizilbash","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjmed.2016.09.015_bib13","first-page":"704","article-title":"Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy","volume":"4","author":"Geske","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Cardiovasc Interv"},{"key":"10.1016\/j.amjmed.2016.09.015_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.09.015_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.112.000849","article-title":"Predictors of long-term outcomes in symptomatic hypertrophic cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib16","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.111.076257","article-title":"Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy","volume":"126","author":"Sorajja","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jchf.2014.06.012","article-title":"Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy","volume":"2","author":"Vriesendorp","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjmed.2016.09.015_bib18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.01.023","article-title":"Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy","volume":"67","author":"Maron","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2016.09.015_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0002-9149(91)90450-Y","article-title":"Prognosis of nonobstructive hypertrophic cardiomyopathy","volume":"67","author":"Aron","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2016.09.015_bib20","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2015.06.018","article-title":"Comparison of outcomes in patients with nonobstructive, labile-obstructive, and chronically obstructive hypertrophic cardiomyopathy","volume":"116","author":"Pozios","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2016.09.015_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.mayocp.2016.01.004","article-title":"Nonobstructive hypertrophic cardiomyopathy: overlooked but not forgotten","volume":"91","author":"Maron","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjmed.2016.09.015_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.mayocp.2016.01.002","article-title":"The natural history of nonobstructive hypertrophic cardiomyopathy","volume":"91","author":"Hebl","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjmed.2016.09.015_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9343(63)90159-1","article-title":"Idiopathic myocardial hypertrophy without congestive heart failure or obstruction to blood flow: clinical, hemodynamic and angiocardiographic studies in 14 patients","volume":"35","author":"Braunwald","year":"1963","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.amjmed.2016.09.015_bib24","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jcmg.2016.05.003","article-title":"The remarkable 50 years of imaging in hypertrophic cardiomyopathy and how it has changed diagnosis and management: from M-mode echocardiography to cardiovascular magnetic resonance","volume":"9","author":"Maron","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjmed.2016.09.015_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.amjcard.2007.09.111","article-title":"Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy","volume":"101","author":"Elesber","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2016.09.015_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2016.09.015_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjcard.2007.09.085","article-title":"Heart transplantation in hypertrophic cardiomyopathy","volume":"101","author":"Biagini","year":"2008","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.amjmed.2016.09.015_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCHEARTFAILURE.114.001435","article-title":"Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant","volume":"7","author":"Rowin","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjmed.2016.09.015_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0002-9149(93)91136-6","article-title":"Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation","volume":"72","author":"Shirani","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2016.09.015_bib30","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/CIRCHEARTFAILURE.114.001843","article-title":"Clinical spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy","volume":"8","author":"Pasqualucci","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjmed.2016.09.015_bib31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCHEARTFAILURE.109.922872","article-title":"Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy","volume":"3","author":"Maron","year":"2010","journal-title":"Circ Heart Fail"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934316310221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934316310221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:12:14Z","timestamp":1757581934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934316310221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0002934316310221"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.09.015","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored \u2026 Until Now","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}